Qualcomm-Arm jury breaks without a verdict as Qualcomm seeks a five-year royalty holiday

The jury in QCOM's contract suit against ARM deliberated for about four hours on Friday, Oct 9, without reaching a verdict and indicated it would return on Tuesday, Oct 13, Reuters reported. Qualcomm is the plaintiff: it says Arm breached a pricing term that keeps its payments within 10% of the lowest price Arm charges for its designs, withheld software patches and tools, and leaked a 2024 letter to Bloomberg to undermine Qualcomm's dealings with META. Arm's response: "They were not harmed in the least".

The real stakes sit in the remedy. Qualcomm asked Judge Maryellen Noreika to rule that a clause lets it stop paying royalties for five years if a breach is proven; she has not ruled, and Arm says the clause is unenforceable. Tech Times puts the royalties at about $300 million per year according to analyst estimates, roughly $1.5 billion over five years, while Electronics Weekly uses $450 million a year. TIKR notes that Qualcomm accounted for 9% of Arm's $4.92 billion revenue in the fiscal year ended March 31, 2026, about $443 million, and stresses that this is a scale comparison, not an estimate of the disputed payments. A $440 million figure in one headline is not tied to the Arm case in reporting we read; it matches ParkerVision's own damages estimate in a separate patent suit against Qualcomm.

The case also reaches the next licence generation. Forbes/Tirias reports Arm's proposed v10 increase at approximately 185 times the existing rate, Tech Times quotes Qualcomm's CEO testifying to "a 1,800% increase over ARMv9", and Electronics Weekly cites 18,500%; the sources disagree on the size. Whether Arm negotiates in good faith is a question for the judge in a separate bench trial, not the jury. The licence runs until 2033.

TipRanks reported QCOM fell 2% to about $173 on Friday morning and lists a Hold consensus with an average price target of $197.04. What to watch: the jury's return on Oct 13, Judge Noreika's ruling on the five-year royalty clause, and the bench-trial decision on good faith, which may come well after the verdict.